Exhibit 5.1

| | | | |
| | 601 Lexington Avenue New York, NY 10022 United States +1 212 446 4800 www.kirkland.com | | Facsimile: +1 212 446 4900 |
December 2, 2020
Oaktree Acquisition Corp.
333 South Grand Avenue, 28th Floor
Los Angeles, California 90071
Ladies and Gentlemen:
We have acted as special legal counsel to Oaktree Acquisition Corp., a Cayman Islands exempted company (“OAC”), in connection with the Registration Statement on Form S-4, initially filed with the U.S. Securities and Exchange Commission (the “Commission”) on October 23, 2020, as amended and supplemented through the date hereof, pursuant to the Securities Act of 1933, as amended (the “Act”) (such Registration Statement, as amended or supplemented, is hereafter referred to as the “Registration Statement”), relating to the Agreement and Plan of Merger, dated September 30, 2020 (the “Agreement and Plan of Merger”), by and among OAC, Rx Merger Sub, Inc., a Delaware corporation (“OAC Merger Sub”), and Hims, Inc., a Delaware corporation (“Hims”). Pursuant to the Agreement and Plan of Merger, OAC will change its jurisdiction of incorporation from the Cayman Islands to Delaware (the “Domestication”) pursuant to Part XII of the Companies Law (Revised) of the Cayman Islands and domesticate as a Delaware corporation in accordance with Section 388 of the General Corporation Law of the State of Delaware (the “DGCL”) by filing a certificate of corporate domestication simultaneously with a certificate of incorporation, in each case in respect of OAC with the Secretary of State of the State of Delaware (the “Delaware Secretary of State”). The Domestication is subject to the approval of the shareholders of OAC. We refer herein to OAC following effectiveness of the Domestication as “New Hims.”
Promptly following the consummation of the Domestication, OAC Merger Sub will merge with and into Hims (the “Merger” and together with the Domestication and related transactions, the “Business Combination”), with Hims as the surviving company in the Merger and, after giving effect to the Merger, Hims will be a wholly-owned subsidiary of OAC (the time that the Merger becomes effective being referred to as the “Effective Time”). In connection with the Domestication, on the date of closing prior to the Effective Time, (i) each issued and outstanding Class A ordinary share, par value $0.0001 per share, of OAC (the “Class A Ordinary Shares”) and each issued and outstanding Class B ordinary share, par value $0.0001 per share, of OAC (the “Class B Ordinary Shares”) will convert automatically by operation of law, on a one-for-one basis, into shares of Class A common stock, par value $0.0001 per share, of New Hims (the “New Hims Class A Common Stock”); and (ii) each issued and outstanding whole warrant of OAC to purchase Class A ordinary shares of OAC (the “Warrants”) will automatically represent the right to purchase one share of New Hims Class A Common Stock at an exercise price of $11.50 per share on the terms and conditions set forth in the warrant agreement, dated July 22, 2019, between OAC and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agreement”).
This opinion is being rendered in connection with the registration under the above-referenced Registration Statement of (i) 23,898,437 shares of New Hims Class A Common Stock, representing (a) 20,125,000 Class A Ordinary Shares and (b) 3,773,437 Class B Ordinary Shares, (ii) 9,720,833 shares of New Hims Class A Common Stock to be issued upon the exercise of Warrants (the “Warrant Shares”) and (iii) 9,720,833 Warrants.